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NITRIC OXIDE AND ALLYL ALCOHOL INDUCED HEPATOTOXICITY
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I. YA. HORBACHEVSKY TERNOPIL STATE MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
Background. Nitric oxide (NO) is an important mediator of hepatotoxicity. NO in liver can be derived from
two sources: (1) constitutive NO synthase (eNOS) in endothelial cells, and (2) inducible NO synthase (iNOS) in
hepatocytes and Kupffer cells.
Objectives. The present study was aimed to examine the effect of nonselective NOS inhibitor (L-NAME)
and selective iNOS inhibitor (1400W) on the development of allyl alcohol (AA) induced hepatitis in rats.
Methods. Male Wistar rats were treated with intraperitoneal injection of saline or AA and L-NAME or
1400W. NO in liver was measured by electrochemical method after eNOS stimulation by calcium ionophore.
Total NOS activity and nitrite/nitrate content were measured in liver and blood serum. The activity of free
radical oxidation in liver was measured by chemiluminescent method. Alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) activities were assayed in blood serum
Results. AA increased the activity of free radical processes in liver and markers of cytolysis in serum, as
well as decreased eNOS and increased iNOS activities. L-NAME considerably inhibited eNOS and augmented
the necrosogenic properties of AA, whereas 1400W partially prevented liver damage.
Conclusion. It has been concluded that in AA intoxication NO produced from eNOS is beneficial to the
liver, but NO derived from the upregulated iNOS has deleterious effect.
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Introduction
Allyl alcohol (AA) is a well known hepatotoxin
widely used in animal experiments to induce liver
necrosis. AA in hepatocytes is oxidized to acrolein
by alcohol dehydrogenase [1]. Acrolein is a potent
electrophile being able to attack nucleophilic
molecules, e.g. sulfhydryl groups of reduced
glutathione. The depletion of reduced glutathione
affects the glutathione peroxidase antioxidant
mechanisms and results in the activation of free
radical oxidation. It has been suggested that the
oxidative stress is the key event leading to liver
necrosis in AA intoxication [2]. We used the AA model
of hepatocyte cell damage in order to investigate
the role of nitric oxide (NO) in the pathogenesis of
necrotic liver injury. Nitric oxide (NO) is an important
mediator of hepatotoxicity, and changes in its
generation are paradoxically implicated in both
cytoprotection and cytotoxicity [3]. NO in liver can
be derived from two sources. Hepatocytes and
Kupffer cells contain inducible NO synthase (iNOS),
activity of which is markedly increased in in-
flammation. Endothelial cells contain constitutive NO
synthase (eNOS). NO produced by eNOS plays
important role in liver microcirculation. It has been
shown that aminoguanidine, a relatively selective
inhibitor of iNOS, protected against acetaminophen-
induced hepatotoxicity [4], as well as thioacetamide-
induced hepatotoxicity [5]. Another study concluded
that iNOS plays an important role in liver cirrhosis
following CCl4 intoxication to rats [6]. Recently, we
have demonstrated that N-(3-(Aminomethyl)ben-
zyl)acetamidine (1400W), a strongly selective
inhibitor of iNOS, prevented the depletion of reduced
glutathione level in liver injured by allyl alcohol (AA)
[7]. At the same time, in acute hepatitis caused by
thioacetamide, methyl ester of N-nitro-L-arginine
(L-NAME), the nonselective inhibitor of NOS,
increased liver damage [8].
The present work was carried out to study the
effects of nonselective (L-NAME) and selective iNOS
(1400W) inhibitors on the formation of NO in liver in
AA intoxication, as well as to investigate the
correlation between NO production and severity of
the liver damage.
Methods
Animals and treatment
Male Wistar rats weighing 250-300 g were used
in experiment. The animals were maintained under
control conditions (23 °C, 12-hour light-dark cycle)
with water and standard laboratory chow being
available ad libitum. All rats were randomly assigned
to four groups of ten animals each. Rats from the first
group were treated with intraperitoneal (i.p.) injection
of saline and served as a control. AA (30 mg/kg) was
diluted in saline and administered one time
intraperitoneally into rats of the second, third and
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fourth groups. Third and fourth groups animals re-
ceived correspondingly L-NAME (10 mg/kg, i.p.) and
1400W (1.5 mg/kg, i.p.) 30 min prior to AA injection.
On the next day of experiment rats were anesthetized
with a mixture of 100 mg/kg ketamine and 10 mg/kg
xylazine and liver was dissected to carry out the
studies described below. Blood was also taken for
the analysis.
All procedures were in compliance with national
and international laws and guidelines for the use of
animals in biomedical research [9].
Measurement of NO in liver
The measurement of NO was performed with
highly sensitive electrochemical nanosensor which
was prepared as previously described [10]. Briefly,
a carbon fiber (tip diameter about 500 nm) was
covered with polymeric film of nickel (II) tetrakis
(3-methoxy-4-hydroxy-phenyl) porphyrin. Measu-
rements were performed using a three-electrode
system that consisted of a nanosensor as the
working electrode, a platinum counter electrode, and
a silver-silver chloride reference electrode.
Liver tissue was cut into thin pieces of 5–6 mm
in length using a razor blade and slices were placed
on the bottom of thermostated organ chamber filled
with Hank’s solution. Counter and reference
electrodes were positioned in the chamber near the
liver slice and the active tip of the nanosensor was
lowered near (2–4 m) the surface of liver tissue
with the aid of micromanipulator.
To stimulate the release of NO, 10 l of eNOS
receptor independent agonist calcium ionophore
A23187 was injected with a nanoinjector onto the
surface of liver slice to reach a final concentration in
the medium of 1 mol/L.
The changes in NO concentration from the
background level were monitored with time (am-
perometry) with a computer-based Gamry VFP600
multichannel potentiostat (detection limit of 1 nmol/
L and resolution time <50 ms). NO concentration
was calculated by means of a calibration curve.
Measurement of the total NOS activity in liver and
nitrite/nitrate content in liver and blood serum
The activity of NO generating system was
assayed in 40 mM Tris HCl buffer, pH 8, containing
liver homogenate (1 mg of protein/ml), 4 mM FAD,
4 mM H
4
biopterin, 3 mM dithiothreitol, and 1 mM
L-arginine. The reaction was initiated by adding
NADPH (2 mM) and run for 3 h at 37 °C [11]. The
combined concentration of nitrite and nitrate, which
accumulate quantitatively as the stable oxidation
products of NO, was determined as described below.
Measurement of the nitrite/nitrate concentration
The combined nitrite/nitrate concentration in the
NO generating system as well as in liver homogenate
and blood serum was assayed after the reduction of
nitrite to nitrate by cadmium using improved Griess
method with the help of commercially available
QuantiChromTM Nitric Oxide Assay Kit (BioAssay
Systems).
Free Radical Oxidation Assay
The activity of free radical oxidation in liver
homogenate was measured by chemiluminescent
method [12].
Evaluation of Hepatotoxicity
Serum alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) activities were
assayed as the markers of hepatocellular death using
commercially available kits (Sigma-Aldrich).
Statistical analysis
Values are expressed as mean±SEM from 4 to
6 experiments. Values P<0.05 are considered as
statistically significant. Statistical analysis was
performed using ANOVA followed by the Student
t test.
Results
The release of NO was measured ex-vivo using
electrochemical nanosensors placed on the surface
of the liver tissue.  We stimulated NO release by a
calcium ionophore, as it causes a large increase in
intracellular calcium, rapid eNOS activation and
maximal receptor-independent NO production. So
far as, iNOS is not sensitive to Ca2+, we can assume
that the amount of NO measured by this method
directly reflects the functional state of the eNOS
located in the hepatic sinusoidal endothelial cells.
The maximum or peak concentration of released NO
from the liver of control rats was 160.0±12.2 nmol/L
(Figure 1). By contrast, stimulation of liver from the
AA injured animals resulted in an approximately two-
fold reduction in the amount of NO release.
Administration of the nonselective NOS inhibitor
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Fig. 1. The effect of L-NAME and 1400W on calcium iono-
phore (A23187, 1 mmol/L) stimulated nitric oxide release from
liver of AA-treated rats. Rats were given AA (30 mg/kg, i.p.)
with or without the administration of L-NAME (10 mg/kg, i.p.)
or 1400W (1.5 mg/kg, i.p.) 30 min before AA. * — significantly
different from control, p<0.05; # — significantly different from
AA alone, p<0.05.  Values are mean±SEM of 5–6 rats.
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Fig. 2. The effect of L-NAME and 1400W on the total NOS activity
in liver of AA-treated rats. Rats were given AA (30 mg/kg, i.p.)
with or without the administration of L-NAME (10 mg/kg, i.p.)
or 1400W (1.5 mg/kg, i.p.) 30 min before AA. * — significantly
different from control, p<0.05; # — significantly different from
AA alone, p<0.05.  Values are mean±SEM of 6–8 rats.
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Fig. 3. The effect of L-NAME and 1400W on the combined
nitrite/nitrate content in blood serum and liver of AA-treated
rats. Rats were given AA (30 mg/kg, i.p.) with or without the
administration of L-NAME (10 mg/kg, i.p.) or 1400W (1.5 mg/kg,
i.p.) 30 min before AA. * — significantly different from control,
p<0.05; # — significantly different from AA alone, p<0.05.
Values are mean±SEM of 6–8 rats.
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Fig. 4. The effect of L-NAME and 1400W on the chemilumi-
nescence intensity of AA-treated rats liver homogenate. Rats
were given AA (30 mg/kg, i.p.) with or without the admi-
nistration of L-NAME (10 mg/kg, i.p.) or 1400W (1.5 mg/kg,
i.p.) 30 min before AA. * — significantly different from control,
p<0.05; # — significantly different from AA alone, p<0.05.
Values are mean±SEM of 6–8 rats.
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Fig. 5. The effect of L-NAME and 1400W on ALT and AST
activities in blood serum of AA-treated rats. Rats were given
AA (30 mg/kg, i.p.) with or without the administration of
L-NAME (10 mg/kg, i.p.) or 1400W (1.5 mg/kg, i.p.) 30 min
before AA. * — significantly different from control, p<0.05;
# — significantly different from AA alone, p<0.05. Values are
mean±SEM of 6–8 rats.
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L-NAME markedly decreased the peak NO release
(more than in five times, as compared to control),
whereas iNOS inhibitor 1400W did not change the
NO production significantly.
In contrast to the calcium ionophore stimulated
NO yield, the activity of NO generating system was
about 1.5-fold increased after intoxication, thereby
suggesting that AA liver damage is accompanied by
the considerable iNOS induction (Figure 2). Both
L-NAME and 1400W significantly diminished the total
NOS activity.
Serum and liver nitrite/nitrate concentrations
correlated well with total NOS activity and were
significantly increased 24 hours after AA admi-
nistration (Figure 3). Both inhibitors effectively
prevented the increase in nitrite/nitrate level.
The activity of free radical oxidation evaluated
by the intensity of spontaneous chemiluminescence
of the liver homogenate was almost three-fold higher
in the poisoned animals in comparison with control
(Figure 4). It is worth noting that 1400W significantly
inhibited the free radical processes in hepatocytes,
whereas L-NAME administration resulted in the
increase of the chemiluminescence intensity.
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The activities of serum ALT and AST indicate
the presence of hepatocyte cytolysis in animals
treated with AA. These markers were especially
elevated in the group administered with AA and
L-NAME, which suggests significant damage of
hepatocyte membranes in these rats (Figure 5).
iNOS inhibitor partially decreased ALT and AST
activity, as compared to the animals treated with AA
alone.
Discussion
It is generally accepted that NO is an important
regulator in the hepatotoxicity of many chemicals [4,
5, 6]. However, the role of NO in the development of
liver necrosis is still not fully known and demands
further studies. NO is reported to be produced in liver
by both eNOS (endothelial cells) and iNOS (paren-
chymal and Kupffer cells). Previously we have shown
that necrosogenic poison AA sharply decreases the
reduced glutathione content in hepatocytes but
inhibition of iNOS partially prevents this effect [7]. In
this study we demonstrate that AA rapidly upregulates
iNOS in liver. Depletion of the glutathione may weaken
cellular antioxidant defense to such a point that the
NO produced by iNOS may cause tissue injury. This
suggestion is confirmed by our observation. The
activity of iNOS as well as the intensity of free radical
processes in liver tissue and the markers of cytolysis
in serum (ALT and AST), which were markedly
increased after AA injection, went down significantly
in animals treated with the strongly selective iNOS
inhibitor 1400W. These results distinctly show that
the upregulation of iNOS in macrophages and
hepatocytes following by the activation of free radical
reactions in liver cells may be at least one of the AA
necrosogenic effect mechanisms.
We also demonstrate here that in contrast to
iNOS, hepatic eNOS is significantly inhibited in liver
necrosis. This effect of AA, like the activation of iNOS,
can also be the reason of the necrotic liver damage.
After administration of the nonselective NOS inhibitor
L-NAME we observed the deep depression of eNOS
activity simultaneously with the considerable raise
of the chemiluminescence intensity in liver and
cytolytic markers activity in serum. This phenomenon
can be be explained by the role of NO derived from
eNOS in maintaining perfusion, and preventing
hypoxia, platelet adhesion and thrombosis in liver
capillaries.
Conclusion
In the AA intoxication NO produced from eNOS
is clearly beneficial to the liver, whereas the inducible
NO production has an opposite effects. Further
research should provide a solid basis for therapeutic
approaches to either supplement NO to the liver for
its protective effect or suppress iNOS to prevent liver
damage.
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